Last reviewed · How we verify

Glyceryl trinitrate 0.5

Recep Tayyip Erdogan University · FDA-approved active Small molecule Quality 5/100

Glyceryl trinitrate 0.5 is a Small molecule drug developed by Recep Tayyip Erdogan University. It is currently FDA-approved. Also known as: Nitroglycerin, Perlinganit.

At a glance

Generic nameGlyceryl trinitrate 0.5
Also known asNitroglycerin, Perlinganit
SponsorRecep Tayyip Erdogan University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Glyceryl trinitrate 0.5

What is Glyceryl trinitrate 0.5?

Glyceryl trinitrate 0.5 is a Small molecule drug developed by Recep Tayyip Erdogan University.

Who makes Glyceryl trinitrate 0.5?

Glyceryl trinitrate 0.5 is developed and marketed by Recep Tayyip Erdogan University (see full Recep Tayyip Erdogan University pipeline at /company/recep-tayyip-erdogan-university).

Is Glyceryl trinitrate 0.5 also known as anything else?

Glyceryl trinitrate 0.5 is also known as Nitroglycerin, Perlinganit.

What development phase is Glyceryl trinitrate 0.5 in?

Glyceryl trinitrate 0.5 is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing